Michael Bishop to Lymphoma, B-Cell
This is a "connection" page, showing publications Michael Bishop has written about Lymphoma, B-Cell.
Connection Strength
1.671
-
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States. Adv Ther. 2022 08; 39(8):3678-3695.
Score: 0.725
-
The benefit of CAR T cells in older patients. Blood. 2020 06 04; 135(23):2020-2021.
Score: 0.629
-
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biol Blood Marrow Transplant. 2020 07; 26(7):1239-1246.
Score: 0.156
-
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013 Dec 12; 122(25):4129-39.
Score: 0.099
-
Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma. Am J Surg Pathol. 2007 Mar; 31(3):476-80.
Score: 0.063